UHS Earnings Prediction
The chart below shows how UHS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, UHS sees a -0.62% change in stock price 10 days leading up to the earnings, and a +1.36% change 10 days following the report. On the earnings day itself, the stock moves by -0.46%. This data can give you a slight idea of what to expect for the next quarter's release.
UHS Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
3.96B
11.23%
1.42%
Gross Margin
--
--
--
Operating Margin
9.69%
20.97%
-13.25%
Net Margin
6.71%
42.16%
-10.89%
EPS
3.80
58.33%
-10.80%
No Data Available
UHS Earnings Analysis
Universal Health Services, Inc. Class B Corporation (UHS.N) Earnings Conference Call
Positive
Net Income Performance: The company recorded net income attributable to UHS per diluted share of $3.80 for the third quarter of 2024, reflecting a solid performance.
Acute Hospital Admissions Growth: Adjusted admissions to our acute hospitals increased 1.5% year-over-year, indicating growth in patient volume.
Solid Revenue Growth: Overall revenue growth was still a solid 8.6% excluding the impact of our insurance subsidiary, showcasing strong operational performance.
EBITDA Growth in Hospitals: EBITDA at our acute care hospitals increased 36% during the third quarter of 2024 compared to the comparable prior year quarter, demonstrating improved profitability.
Operating Cash Flow Improvement: Cash generated from operating activities was $1.4 billion during the first nine months of 2024, compared to $815 million during the same period in 2023, indicating significant cash flow improvement.
Negative
Net Income Per Share Decline: The company recorded net income attributable to UHS per diluted share of $3.80 for the third quarter of 2024, which is a decrease from the adjusted net income of $3.71 for the quarter ended September 30, 2023.
Acute Hospital Admissions Growth: Adjusted admissions to our acute hospitals increased 1.5% year-over-year, with surgical growth slowing down.
Premium Pay Decline: The amount of premium pay in the third quarter was $60 million, reflecting a 12% decline from the prior year quarter.
Medicaid Reimbursement Increase: We recorded aggregate net incremental reimbursements of approximately $20 million in connection with various state supplemental Medicaid programs, approximately half of which was earned by our acute care hospitals.
Debt Extinguishment Loss: We had a $5 million loss on the extinguishment of debt related to our refinancing that we did during the quarter.
UHS FAQs
How does UHS typically perform around its earnings report dates?
Is Universal Health Services, Inc. (UHS) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
UHS Earning Call Sentiment
Universal Health Services, Inc. (UHS) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
UHS.N
3.3%Positive
The earnings call reflects strong financial performance with an 8.6% revenue growth and increased EBITDA. The share repurchase program boosts shareholder value, and margin recovery is underway. Despite some competitive pressures and liability risks, the company provides optimistic guidance and expects continued growth. Positive sentiment is reinforced by management's strategy and expansion plans, outweighing minor concerns in the Q&A section. Given the positive financial metrics and strategic initiatives, a positive stock price movement is likely over the next two weeks.
